Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial - Yau, Thomas; Kang, Yoon-Koo; Kim, Tae-You; El-Khoueiry, Anthony B; Santoro, Armando; Sangro, Bruno; Melero, Ignacio; Kudo, Masatoshi; Hou, Ming-Mo; Matilla, Ana; Tovoli, Francesco; Knox, Jennifer J; et al. (JAMA oncology, 2020)
Keywords: Antineoplastic Combined Chemotherapy Protocols - adverse effects; Carcinoma, Hepatocellular - drug therapy; Carcinoma, Hepatocellular - etiology; Humans; Ipilimumab - therapeutic use; Liver Neoplasms - drug therapy; Liver Neoplasms - etiology; Male; Nivolumab - therapeutic use; Sorafenib - therapeutic use